Chen Irene E - Temple City, California 91780

Chen Irene E is categorized under Acupuncturists in Temple City, CA .

Business Name: Chen Irene E
Contact Person: Irene Chen
Address: 5610 1/2 Rosemead Boulevard, Temple City, California 91780
Phone Number: (626) 380-6465
Website Address: chenacupunctureca.com
Annual Revenue (USD): $100.000 to $499.999
Founding Year: 2009
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Acupuncturists
SIC Code: 8049
NAICS Code: 6213990
Share This Business:
Related Businesses: G D Acupuncture Corp - Temple City, CA 91780
Rosemead Acupuncture Clinic - Temple City, CA 91780
Grace & Quin Acupuncture - Temple City, CA 91780
Choice Health Clinic - Temple City, CA 91780
Livewell Acupuncture & Herbs - Temple City, CA 91780
Karen Wang - Temple City, CA 91780
S Herb Oh Acupuncture - Temple City, CA 91780
Chinese Acupuncture Medical Clinic - Temple City, CA 91780
Clinica DE Medicina Oriental - Temple City, CA 91780
Arcadia Acupuncture Group - Temple City, CA 91780
United Acupuncture Association - Temple City, CA 91780
Revive Acupuncture - Temple City, CA 91780
Tsui Shuching - Temple City, CA 91780
Hong Zhen-Li - Temple City, CA 91780
Im Hwa C - Temple City, CA 91780
Wang Wenchi - Temple City, CA 91780

The company Chen Irene E provides B2C services in the form of Acupuncturists from its single location in California. 1 to 4 employees work for Chen Irene E, and the business now earns $100.000 to $499.999 per annum.

Chen Irene E was launched in 2009 and is classified under SIC code and category 8049 , and NAICS number and grouping 6213990 . To contact Chen Irene E, please call Irene Chen with the phone number (626) 380-6465 or visit its single location at 5610 1/2 Rosemead Boulevard in Temple City, California 91780.

The location of the single location can also be found using the coordinates 34.10128,-118.07341. Read more details about this business on the webpage chenacupunctureca.com or follow the company’s social media accounts, on Twitter and on Facebook.